Implementation Guide CH VACD
3.0.0 - STU3
This page is part of the CH VACD (R4) (v3.0.0: STU 3) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 6.0.0. For a full list of available versions, see the Directory of published versions
| Official URL: http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-recommendation-forecast-status-cs | Version: 3.0.0 | |||
| Active as of 2022-12-21 | Computable Name: SwissRecommendationForecastStatusCodesystem | |||
| Other Identifiers: id: entry-conflict (use: OFFICIAL) | ||||
Copyright/Legal: CC-BY-SA-4.0 |
||||
Swiss Recommendation Forecast Status Codesystem
This Code system is referenced in the content logical definition of the following value sets:
This CodeSystem is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
This code system http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-recommendation-forecast-status-cs defines the following codes:
Additional Language Displays
| Code | Deutsch (Schweiz) (German (Switzerland), de) | English (United States) (English (United States), en) | French (Switzerland) (fr) | Italian (Switzerland) (it) | rm |
| due | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. | The patient is due for their next vaccination. |
| overdue | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. | The patient is considered overdue for their next vaccination. |
| immune | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. | The patient is immune to the target disease and further immunization against the disease is not likely to provide benefit. |
| consultadvise | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. | The patient may be contraindicated but get health care advice. |
| indicated | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. | The patient is indicated for further doses. |
| contraindicated | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. | The patient is contraindicated for further doses. |
| complete | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. | The patient is fully protected and no further doses are recommended. |
| notrelevant | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. | There is no relevance for this patient. |